Pfizer Expects To Pay $772M To End Hormone Drug Suits
By Erin Fuchs ( May 13, 2011, 5:53 PM EDT) -- Pfizer Inc. said Thursday that it had resolved one-third of the suits filed over its hormone replacement therapy and that the drug company expected to spend at least $772 million to end all of the product liability fights....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.